Search research articles
Contact Us
Filters
Showing results (201-210 of 241) with videos related to
Page
of 25
Sort By:
Zeitschrift Fur Rheumatologie
|
June 29, 2014
Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility
Y H Lee, S-C Bae, J-H Kim, et al.
Journal of Human Hypertension
|
November 16, 2012
Lack of association between STK39 and hypertension in the Chinese population
J Xu, L D Ji, L N Zhang, et al.
Canadian Journal of Microbiology
|
July 27, 1999
Sequence analysis of the Gluconobacter oxydans RecA protein and construction of a recA-deficient mutant
Y T Liu, C G Chen, D C Chao, et al.
Rheumatology (Oxford, England)
|
April 21, 2005
Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2
J D Ji, H J Kim, Y H Rho, et al.
Journal of Molecular Recognition : JMR
|
December 1, 1989
Agonist derived molecular probes for A2 adenosine receptors
K A Jacobson, L K Pannell, X D Ji, et al.
Journal of Applied Microbiology
|
November 7, 2012
Long PCR-RFLP of 16S-ITS-23S rRNA genes: a high-resolution molecular tool for bacterial genotyping
Y H Zeng, M Koblížek, Y X Li, et al.
ESMO Open
|
May 13, 2023
Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
C Mao, D Ji, Y Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2000
A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
K Mishima, A P Mazar, A Gown, et al.
Journal of Medicinal Chemistry
|
February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors
P G Baraldi, B Cacciari, G Spalluto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 1996
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
S Y Cheng, H J Huang, M Nagane, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 241) with videos related to
Sort By:
Page
of 25
Zeitschrift Fur Rheumatologie
|
June 29, 2014
Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility
Y H Lee, S-C Bae, J-H Kim, et al.
Journal of Human Hypertension
|
November 16, 2012
Lack of association between STK39 and hypertension in the Chinese population
J Xu, L D Ji, L N Zhang, et al.
Canadian Journal of Microbiology
|
July 27, 1999
Sequence analysis of the Gluconobacter oxydans RecA protein and construction of a recA-deficient mutant
Y T Liu, C G Chen, D C Chao, et al.
Rheumatology (Oxford, England)
|
April 21, 2005
Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2
J D Ji, H J Kim, Y H Rho, et al.
Journal of Molecular Recognition : JMR
|
December 1, 1989
Agonist derived molecular probes for A2 adenosine receptors
K A Jacobson, L K Pannell, X D Ji, et al.
Journal of Applied Microbiology
|
November 7, 2012
Long PCR-RFLP of 16S-ITS-23S rRNA genes: a high-resolution molecular tool for bacterial genotyping
Y H Zeng, M Koblížek, Y X Li, et al.
ESMO Open
|
May 13, 2023
Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
C Mao, D Ji, Y Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2000
A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
K Mishima, A P Mazar, A Gown, et al.
Journal of Medicinal Chemistry
|
February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors
P G Baraldi, B Cacciari, G Spalluto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 1996
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
S Y Cheng, H J Huang, M Nagane, et al.
Page
of 25